Edition:
United Kingdom

OHR Pharmaceutical Inc (OHRP.OQ)

OHRP.OQ on NASDAQ Stock Exchange Capital Market

0.25USD
19 Oct 2018
Change (% chg)

-- (--)
Prev Close
$0.25
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
115,512
52-wk High
$2.17
52-wk Low
$0.15

Chart for

About

Ohr Pharmaceutical, Inc. is a pharmaceutical company focused on the development of therapeutics and delivery technologies for the treatment of ocular disease. The Company's development pipeline consists of several programs and indications at various stages of development. Its product pipeline includes Squalamine Lactate... (more)
No analyst recommendations are available for .

Overall

Beta: 0.36
Market Cap(Mil.): $39.03
Shares Outstanding(Mil.): 56.21
Dividend: --
Yield (%): --

Financials

  OHRP.OQ Industry Sector
P/E (TTM): -- 85.41 33.64
EPS (TTM): -0.70 -- --
ROI: -88.21 0.21 14.27
ROE: -88.44 1.17 15.99

Competitors

  Price Chg
Roche Holding Ltd. (ROG.S) CHF242.50 -2.45
Roche Holding Ltd. (RO.S) CHF242.80 -2.40
Regeneron Pharmaceuticals Inc (REGN.OQ) $389.83 --
Amgen, Inc. (AMGN.OQ) $201.80 --
Novartis AG (NOVN.S) CHF86.40 -0.64
Allergan plc (AGN.N) $189.53 +0.64

Earnings vs. Estimates